The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 1st 2025
In clinical trials, the dihydroergotamine (DHE) nasal powder had favorable safety profiles and rapid pain relief in patients with migraine with or without aura.
FDA Approves Furosemide Injection for Congestion in Patients with Chronic Heart Failure
October 10th 2022Furosemide injection 80 mg/10 mL (Furoscix; scPharmaceuticals) is indicated for the at-home treatment of congestion caused by fluid overload in adult patients with New York Heart Association Class II/III chronic heart failure.
Read More
Trends in Behavioral and Mental Health Treatment Since the Start of the Pandemic
October 10th 2022New research finds that mental health has replaced COVID-19 as the top health concern among Americans, but deeper analysis needs to be done into whether depression and anxiety are truly becoming more widespread.
Read More
Pharmacist Insights: Descovy and Truvada for HIV Pre-Exposure Prophylaxis
October 10th 2022Clinical studies have shown similar efficacy between emtricitabine and tenofovir alafenamide (Descovy) and emtricitabine and tenofovir disoproxil fumarate (Truvada) for individuals at risk for HIV infection.
Watch
Monkeypox Treatment and Prevention: Stopping the Latest Outbreak
There is not yet an FDA-approved treatment available for monkeypox, but existing antiviral agents have been found to be effective in vitro and in animal studies.
Read More
Acetazolamide Found to Improve Decongestion in Patients With Acute Decompensated Heart Failure
October 7th 2022New research suggests that acetazolamide and standard loop-diuretic therapy may decrease congestion and prevent future hospitalizations in patients with acute decompensated heart failure.
Read More